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Abstract
Osteogenesis imperfecta (OI) is a hereditary disease occurring in humans and dogs. It is characterized by extremely fragile
bones and teeth. Most human and some canine OI cases are caused by mutations in the COL1A1 and COL1A2 genes
encoding the subunits of collagen I. Recently, mutations in the CRTAP and LEPRE1 genes were found to cause some rare
forms of human OI. Many OI cases exist where the causative mutation has not yet been found. We investigated Dachshunds
with an autosomal recessive form of OI. Genotyping only five affected dogs on the 50 k canine SNP chip allowed us to
localize the causative mutation to a 5.82 Mb interval on chromosome 21 by homozygosity mapping. Haplotype analysis of
five additional carriers narrowed the interval further down to 4.74 Mb. The SERPINH1 gene is located within this interval and
encodes an essential chaperone involved in the correct folding of the collagen triple helix. Therefore, we considered
SERPINH1 a positional and functional candidate gene and performed mutation analysis in affected and control Dachshunds.
A missense mutation (c.977C.T, p.L326P) located in an evolutionary conserved domain was perfectly associated with the OI
phenotype. We thus have identified a candidate causative mutation for OI in Dachshunds and identified a fifth OI gene.
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Introduction
Collagen I is the most abundant protein in the human body and
its highly ordered fibril structure is responsible for its special
mechanical properties. Together with inorganic hydroxylapatite it
is the main component of bones and gives them elasticity while the
hydroxylapatite alone would be very brittle. Defects in the structure
of the highly ordered collagen I triple helix lead to osteogenesis
imperfecta (OI), a disease characterized by extremely fragile bones
and teeth. OI is sometimes also accompanied by blue sclera,
hearing loss, dwarfism, dentinogenesis imperfecta, and other
complications. Seven subtypes of human OI are distinguished
based on the underlying genetic defects and phenotypic severity [1].
OI affects an estimated 6 to 7 per 100,000 people worldwide
[http://ghr.nlm.nih.gov/condition=osteogenesisimperfecta/]. Ap-
proximately 85–90% of the human OI cases are caused by
mutations in the COL1A1 or COL1A2 genes encoding the two
different subunits of collagen I. More than 800 distinct mutations
in these two genes have been described and most of them lead to
autosomal dominant forms of OI [2]. The maturation and
correct folding of collagens is a complicated process, which
involves a large number of accessory proteins and chaperones.
Recently mutations in two of these accessory proteins were found
in patients with autosomal recessive forms of OI [3–7]. Both of
these proteins are involved in the 3-hydroxylation of a specific
proline residue in collagen I. One represents the enzymatically
active prolyl-3-hydroxylase 1 itself and is encoded by the LEPRE1
gene [3]. The other is called cartilage-associated protein
(CRTAP) and forms a complex with the prolyl-3-hydroxylase
[4]. For some human OI cases the underlying mutation has not
yet been found.
OI also occurs in dogs and the dog may represent a better
model for human OI than genetically engineered mice because
of its larger body size and the resulting similarity of mechanical
forces that act on the skeleton. OI in dogs has been described in
Golden Retrievers, Beagles, Collies, Poodles, Norwegian Elk-
hounds, and Bedlington Terriers [8–12]. In Golden Retrievers a
COL1A1 mutation and in Beagles a COL1A2 mutation has been
reported to cause OI [8,9]. For other canine OI cases the
underlying genetic defect has not been elucidated. We have
observed a severe form of OI in rough-coated Dachshunds that
is inherited as a monogenic autosomal recessive trait [13]. In our
initial analysis of the OI Dachshunds we did not find any
mutations in the COL1A1 or COL1A2 genes. Therefore, we
hypothesized that a mutation in a novel OI gene may be
responsible for the observed bone defects in Dachshunds.
Consequently, we started a positional cloning approach to
identify this mutation.
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Results
Collection of informative families and exclusion of
COL1A1 and COL1A2
We collected samples from six Dachshund families segregating
for congenital OI (Figure 1; Video S1). The parents of all available
cases were healthy (Figure S1). The pedigrees were consistent with a
monogenic autosomal recessive inheritance although the ratio of
affected Dachshunds from the presumed carrier x carrier matings
was slightly higher than expected with 14 out of 36 total pups
affected instead of the expected 9/36. The available pedigree
records indicate that the affected dogs from the German Dachshund
breeding population share common ancestors and most likely trace
back to a single common founder. As the OI phenotype in
Dachshunds shows striking clinical similarities to human OI forms,
we initially hypothesized that mutations in COL1A1 or COL1A2
might cause the canine disease. In order to validate whether a
mutation in one of these genes might be responsible for OI, we
genotyped three gene associated microsatellite markers derived
from the surrounding genome sequence of COL1A1 (located on
chromosome 9 (CFA 9) at 29.5 Mb) and COL1A2 (located on CFA
14 at 22.8 Mb), respectively. Two-point linkage analysis in the six
available families clearly excluded the COL1A2 gene but indicated a
suggestive linkage of OI to the region of COL1A1 with a positive
LOD score of 1.5 (Table S1). However, the re-sequencing of
COL1A1 using DNA of four affected and four healthy Dachshunds
did not reveal any disease associated sequence polymorphism within
the 51 coding exons and flanking intron regions of the COL1A1
gene. Furthermore, haplotype analysis revealed five different CFA 9
microsatellite marker haplotypes in affected dogs, which was not
compatible with our assumption of a single founder mutation in all
OI affected dogs.
Mapping of the causative mutation
Based on the pedigrees of our samples we hypothesized that the
affected Dachshunds most likely were inbred to one single founder
animal. Under this scenario the affected Dachshunds were expected
to be identical by descent (IBD) for the causative mutation and
flanking chromosomal segments. Therefore, we decided to apply a
homozygosity mapping approach to determine the position of the
mutation in the canine genome. We genotyped approximately
50,000 evenly spaced SNPs from five affected dogs and five obligate
carriers. We analyzed the cases for extended regions of homozy-
gosity with simultaneous allele sharing. Only one genome region
fulfilled our search criteria (Table S2). On CFA 21 all five affected
genotyped dogs were homozygous and shared identical alleles over
102 SNP markers corresponding to a 5.82 Mb interval from 23.58–
29.40 Mb (Figure 2). We then examined the five obligate carriers
for the mutation and reconstructed one copy of the disease-
associated haplotype in each dog. One of the carriers showed a
recombination event, which allowed us to narrow down the critical
interval harboring the causative mutation to 4.74 Mb from 24.66–
29.40 Mb (Figure 2).
Identification of a functional candidate gene and
mutation analysis
As the quality of dog genome annotation is still far from perfect,
we inferred the gene annotation of the mapped interval from the
corresponding human interval. The dog OI interval corresponds
to two human segments from 3.59–3.84 Mb and from 71.30–
76.48 Mb on HSA 11. The two human intervals contain 98
annotated genes including 8 annotated pseudogenes (NCBI
MapViewer, build 36.3). A careful inspection of these genes and
database searches of their presumed function revealed SERPINH1
as a functional candidate gene within the critical interval at
26.0 Mb on CFA 21. SERPINH1 encodes a serine protease
inhibitor, also called heat shock protein 47 (HSP47) or collagen
binding protein 1. Serpinh1 deficient mice die at around day 11 of
development due to defective collagen synthesis [14] and it was
shown that Serpinh12/2 fibroblasts produce abnormally thin and
branched collagen type I fibres [15]. In order to further validate
SERPINH1 as positional candidate gene for OI, we genotyped two
gene associated microsatellite markers derived from the surround-
ing genome sequence of CFA 21 (Table S1). The obtained LOD
score of 4.1 conclusively confirmed the linkage of OI to the
candidate gene region in the Dachshund families. All OI affected
dogs showed homozygosity at both tested microsatellites and all
genotyped parents had one copy of the disease associated
haplotype. We therefore investigated whether mutations in the
canine SERPINH1 gene might be responsible for the OI
phenotype. We designed PCR primers for the amplification of
the four coding exons and determined the genomic sequence of
two affected and two control dogs. This analysis revealed twelve
polymorphisms including three non-synonymous substitutions
(Table 1). Of these polymorphisms only a single SNP located in
SERPINH1 exon 5 (c.977T.C; Figure 3) showed perfect
association to the OI phenotype (Table 2, Figure S1). All 11
affected dogs were homozygous C/C and all 13 known carriers
were heterozygous C/T. One grandmother and 16 out of 22
healthy full- and half-sibs of OI affected dogs were also
heterozygous C/T. None of 66 unrelated healthy Dachshunds
had the homozygous C/C genotype, but twelve of them were also
presumed carriers with the C/T genotype. Thus the allele
frequency of the deleterious C-allele within the unrelated
Dachshunds was 18%. The mutation was encountered in wire-
haired and short-haired Dachshunds. The mutant C-allele was
absent from 79 control dogs from 75 diverse dog breeds (Table
S2). RT-PCR on bone cDNA confirmed that the SERPINH1 RNA
is normally spliced in an affected dog. We sequenced the cDNA
from an affected dog and it did contain the mutant C-nucleotide at
Author Summary
Osteogenesis imperfecta (OI) is a genetic condition of
humans and dogs characterized by extremely fragile bones
and teeth. Most human OI cases are caused by defects in
one of two collagen genes. Mutations in two other genes
related to collagen maturation can also lead to OI in some
patients. We studied Dachshunds with OI and initially
investigated the two known collagen genes that are
normally mutated in OI but did not find a mutation.
Subsequently, we performed a search for shared segments
across the entire genome in five affected Dachshunds. This
experiment revealed that the causative mutation for OI in
Dachshunds is located on dog chromosome 21. The
SERPINH1 gene known to be involved in collagen
maturation is located in this shared genome region. We
sequenced the SERPINH1 gene in healthy and affected
Dachshunds and found a single mutation exclusively
shared by all affected dogs but not by healthy controls.
Thus we have identified SERPINH1 as a fifth OI gene and a
mutation within this gene as the most likely cause of OI in
Dachshunds. The knowledge of this mutation enables
genetic testing and will allow breeders to eradicate the
deleterious allele from the Dachshund breeding popula-
tion. SERPINH1 mutations might also be responsible for
some human OI forms, where the causative mutation has
not yet been identified.
SERPINH1 Mutation in Dogs
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position +977 confirming that the mutant mRNA is expressed at
normal levels. The c.977T.C substitution is predicted to result in
an exchange of a highly conserved leucine to a proline in the
SERPINH1 protein sequence (p.L326P, Figure 4). We modeled
the wildtype and mutant SERPINH1 protein structures based on
experimentally determined structures of serpins and found that the
p.L326P mutation indeed affects the three-dimensional structure
of SERPINH1 (Figure 5).
Figure 1. Radiographs of an OI affected and a control Dachshund demonstrating generalized osteopenia in canine OI. (A) Foreleg of
an affected Dachshund. Note the overall decreased radiopacity of the skeleton with the thin compact bone and inhomogeneous, shallow
trabeculation in the entire foreleg. No pathologic fractures were seen in this puppy. (B) Foreleg of a control Dachshund. (C) Skull of an affected
puppy. There is decreased opacity and poor delineation of the skull. Note the lack of visualization of the lamina dura of the dental alveoli leading to a
‘‘floating’’ appearance of the teeth, which themselves show a lack of mineralization. (D) Skull of a control dog.
doi:10.1371/journal.pgen.1000579.g001
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Discussion
We have applied an efficient SNP-based homozygosity mapping
strategy to map the causative gene for OI in Dachshunds using
only five affected dogs and five obligate carriers. The special
population structure of purebred dog breeds with a limited
amount of inbreeding on the one hand increases the occurrence of
recessive phenotypes and on the other hand provides ideal
prerequisites to map the underlying genes for these traits [16].
In this study we did not have enough high-quality DNA samples of
unrelated Dachshunds for a genome-wide association study.
However, the homozygosity mapping approach for this recessive
trait basically required only samples from the five affected dogs to
map the causative gene to one unique chromosome segment of
5.82 Mb. Adding the five obligate carriers further reduced this
interval to 4.74 Mb. Thus the use of genome-wide canine SNP
genotyping data enables very efficient positional cloning projects of
Mendelian traits even if only very few samples are available.
The mappedOI interval contains a very good functional candidate
gene, SERPINH1. We found a non-synonymous mutation in this
gene, which is perfectly associated with the OI phenotype in
Dachshunds, and confirmed the presence of this mutation on the
genomic DNA and mRNA level. Although we cannot provide
functional proof of the causality of the mutation at this time, the
wealth of functional data, which are available for the SERPINH1
gene, strongly supports the hypothesis that p.L326P is indeed the
causative mutation. SERPINH1 or HSP47 is a molecular chaperone
of the serpin family. It promotes the correct folding of the collagen I
triple helix [17]. This triple-helical structure would normally not be
stable at temperatures above 35 uC. SERPINH1 is present in high
concentration in the endoplasmic reticulum and specifically binds to
and stabilizes the triple helices of nascent collagens [18–20].
Apparently the complete absence of SERPINH1 leads to embryonic
lethality due to deficiencies in several types of collagen [14]. It is an
evolutionary conserved protein with 97% identity between human
and dog and 64% identity between human and zebrafish. The
p.L326P mutation lies within the conserved serpin domain and the
wildtype leucine is conserved across all SERPINH1 sequences while
in other, more distantly related serpins like antitrypsin or ovalbumin,
it is conservatively replaced by isoleucine, valine or methionine. It is
located at the interface of helices hB, hC and hI (Figure 5A) [21].
Leu326 has backbone dihedral angles W/Y of about 290/+88
degrees. Proline has aW-angle restricted to about260 degrees due to
its five-membered ring and most frequentlyY-angles of245 or +135
degrees. Therefore, it is likely that the mutation L326P results in an
increased strain. Furthermore, in the wildtype Leu326 donates a
main-chain H-bond to Leu321 that is not possible with the imino acid
proline (Figure 5B). Thus it is conceivable that this mutation affects
the proper folding and stability of the native conformation, possibly
reducing the protein level significantly. Additionally, this non-
conservative amino acid substitution could affect the ability of
SERPINH1 to bind and stabilize collagen triple helices. We speculate
that the p.L326P mutation in OI affected dogs probably does not
represent a complete null allele but has some residual activity, which
results in live-born dogs with a severe form of OI instead of the
embryonic lethality seen in Serpinh1 knock-out mice. The phenotype
of OI affected dogs primarily indicates a deficiency in collagen I, the
most abundant collagen, whereas basal membranes, which contain
collagen IV, do not seem to be severely altered [13].
Our finding of a SERPINH1 p.L326P mutation in dogs with OI
provides a valuable model for human medicine and identifies
SERPINH1 as a fifth OI gene in addition to COL1A1, COL1A2,
CRTAP, and LEPRE1. It has already been shown that a functional
SNP in the promoter of the human SERPINH1 gene is associated
in African American women with an increased risk for preterm
premature rupture of membranes [22]. Our study indicates that
coding mutations of the SERPINH1 gene might be responsible for
recessive forms of human OI, where no mutation in the four
known OI genes has been found. It has been proposed to develop
SERPINH1 binding molecules as drugs against fibrosis [23]. The
findings of our study emphasize that such a therapeutic strategy
will have to be very carefully adjusted in order not to have adverse
effects on the physiological production of collagen.
In conclusion, we have identified the p.L326P mutation in the
canine SERPINH1 gene as the candidate causative mutation for
OI in Dachshunds. This result allows genetic testing and
eradication of a lethal disease from the Dachshund breeding
population. Our study also provides a defined animal model and a
novel genetic mechanism for a lethal or severely debilitating
human hereditary disease.
Materials and Methods
Animals
We collected samples from OI affected rough-coated Dachshunds
(n=11), their healthy littermates (n=22), sires (n=4), dams (n=7),
Figure 2. Mapping of the OI mutation. SNP genotypes of selected
CFA 21 markers are shown. Alternate SNP alleles are represented in blue
and yellow. The two copies of CFA 21 for each dog are separated by a
vertical dashed line. The analysis of SNP genotypes from five affected
dogs indicated that they had extended homozygous regions on CFA 21
(indicated as blue blocks). The boundaries of these homozygous blocks
are given in Mb. All five affected dogs had homozygous intervals with
shared alleles between 23.58 Mb and 29.40 Mb. We also genotyped five
parents of affected dogs assumed to be carriers of the mutation. One of
these carriers, animal no. 33, had one copy of the disease-associated
haplotype in the critical interval (indicated in blue). In comparison to
the affected dogs it was homozygous for the opposite SNP alleles
(indicated in yellow) at several positions proximal of 24.66 Mb and
distal of 29.40 Mb. Thus – assuming that it resides on the common blue
haplotype block – the causative mutation is located within the interval
from 24.66 Mb to 29.40 Mb on CFA 21.
doi:10.1371/journal.pgen.1000579.g002
SERPINH1 Mutation in Dogs
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and one grandmother. We performed parentage verification to
confirm the pedigree documentation from the breeders (Figure S1).
In addition, we collected two Dachshunds recorded as sires of OI
affected puppies. Parents of affected offspring were classified as
obligate carriers (n=13). We also collected 66 unrelated healthy
Dachshunds resulting in a total of 113 samples from the Dachshund
breed. Furthermore, we sampled 79 control dogs from 75 different
breeds for the re-sequencing of SERPINH1 exon 5 (Table S3).
DNA and RNA extraction
Genomic DNA was isolated from blood or tissue using the
Nucleon Bacc2 kit (GE Healthcare). Total RNA was isolated from
bone or skin using Trizol reagent according to the manufacturer’s
instructions (Invitrogen).
Linkage analysis in candidate genes
Microsatellite markers were amplified using the Multiplex PCR
Kit (Qiagen) and fragment size analyses were determined on an
ABI 3730 capillary sequencer (Applied Biosystems) and analyzed
with the GeneMapper 4.0 software (Applied Biosystems). Two-
point parametric linkage analysis under the assumption of OI
segregating as a biallelic autosomal recessive trait with complete
penetrance was performed with Merlin software version 1.1.2 [24].
The frequency of the mutant allele in the considered population
was unknown and there were no data available that would have
made it possible to estimate the frequency in a reliable manner.
For the calculations a frequency of 0.001 for the mutant allele was
assumed. The LOD score test statistic was used to estimate the
proportion of linked families and the corresponding maximum
heterogeneity LOD score. Within the available families, a
maximum LOD score of 5.573 would have been possible. To
reconstruct the most likely haplotypes, we applied the ‘best’ option
of the Merlin software.
Mapping of the OI mutation
Genomic DNA from five affected Dachshunds and five carriers
was genotyped on the canine Affymetrix version 2 SNP
genotyping microarray (49,663 SNPs). The results were analyzed
with PLINK [http://pngu.mgh.harvard.edu/,purcell/plink/].
To identify extended homozygous regions with allele sharing
across all five affected animals the options –homozyg-group and –
homozyg-match were applied. All given positions correspond to
the build 2.1 dog genome assembly [http://www.ncbi.nlm.nih.
gov/projects/mapview/map_search.cgi?taxid=9615].
Mutation analysis
Primers for the amplification of each of the four SERPINH1
coding exons with flanking regions were designed with the
software Primer3 [http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3_www.cgi] after masking repetitive sequences with Re-
Table 1. SERPINH1 gene polymorphisms
Polymorphism (cDNA)a
Position within
SERPINH1 gene Protein Association with OIb
c.-28C.T exon 2, 59-UTR – Homozygous mutant genotype in OI and control dogs
c.47T.C exon 2 p.V16A Mutant allele only in control dogs
c.83C.T exon 2 p.A28V Homozygous mutant genotype in OI and control dogs
c.471G.A exon 2 silent Homozygous mutant genotype in OI and control dogs
c.621G.A exon 2 silent Mutant allele only in control dogs
c.622+8T.C intron 2 – Mutant allele only in control dogs
c.721+52G.A intron 3 – Mutant allele only in control dogs
c.885A.G exon 4 silent Mutant allele also in a healthy dog from another breed
c.954+28T.C intron 4 – Mutant allele only in control dogs
c.977T.C exon 5 p.L326P Homozygous mutant genotypes exclusively in OI Dachshunds
c.1059C.T exon 5 silent Homozygous mutant genotype in OI and control dogs
c.1107C.T exon 5 silent Mutant allele only in control dogs
aNumbering refers to accession no. XM_542305 (this RefSeq model RNA is incorrectly annotated as SERPINH2, it does represent the putative canine SERPINH1 mRNA
sequence)
bThe canine genome reference sequence was considered to represent the wildtype state. Sequence variants with respect to this sequence are designated ‘‘mutant’’
alleles or genotypes.
doi:10.1371/journal.pgen.1000579.t001
Figure 3. Electropherograms of the SERPINH1 c.977T.C muta-
tion. Representative sequence traces of PCR products amplified from
genomic DNA of three dogs with the different genotypes are shown.
doi:10.1371/journal.pgen.1000579.g003
SERPINH1 Mutation in Dogs
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peatMasker (Smit, A.F.A and Green, P. [http://repeatmasker.
genome.washington.edu/]). The sequences of the primers are
listed in Table S4. For the mutation analysis PCR products were
amplified of two affected and two unrelated healthy dogs using
TopTaq polymerase (Qiagen). The subsequent re-sequencing of
the PCR products was performed after rAPid alkaline phosphatase
(Roche) and exonuclease I (New England Biolabs) treatment using
both PCR primers with the ABI BigDye Terminator Sequencing
Kit 3.1 (Applied Biosystems) on an ABI 3730. Sequence data were
analyzed with Sequencher 4.8 (GeneCodes).
RT–PCR
Aliquots of 1 mg total RNA were reverse transcribed into cDNA
using 20 pmol (T)24V primer and Omniscript reverse transcriptase
(Qiagen). Two microliters of the cDNA were used as a template in
PCR. PCR reactions were performed as described above and
Table 2. SERPINH1 genotype frequencies
Dachshunds Other breeds
SERPINH1 OI affected (n =11) OI carrier (n =13)
Control,
related
(n=23)
Control,
unknown
relationship
(n =66) Controls (n=79)
c.-28C.T CC 4
CT 11 12
TT 11 2 7
c.47T.C TT 11 6 12
(p.V16A) TC 7 8
CC 3
c.83C.T CC 4
(p.A28V) CT 11 12
TT 11 2 7
c.471G.A GG 4
GA 11 12
AA 11 2 7
c.621G.A GG 11 12 19
GA 1 4
AA
c.622+8T.C TT 11 12 19
TC 1 4
CC
c.721+52G.A GG 10a 11 14
GA 2 9
AA
c.885A.G AA 3
AG 10 10
GG 10a 3 10
c.954+28T.C TT 10a 12 19
TC 1 1
CC 3
c.977T.C TT 6 54 79
(p.L326P) TC 13 17 12
CC 11
c.1059C.T CC 4
CT 11 12
TT 11 2 7
c.1107C.T CC 11 12 19
CT 1 4
TT
aLow DNA quality prevented the determination of the genotypes in one amplicon from a single affected dog.
doi:10.1371/journal.pgen.1000579.t002
SERPINH1 Mutation in Dogs
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primer sequences are given in Table S5. The canine SERPINH1
cDNA sequence was deposited under accession FN395288 in the
EMBL nucleotide database.
Homology modeling
Models of wildtype and mutant SERPINH1were produced
employing 3D-JIGSAW [25,26] with template PDB entries1OO8
and 1OPH [27]. Figures were prepared using PyMOL [http://
www.pymol.org].
Supporting Information
Figure S1 Pedigrees of sampled Dachshunds. Animals genotyped
on the SNP chip are indicated by asterisks. The genotypes for the
SERPINH1 c.977T.C mutation are given below the symbols.
Found at: doi:10.1371/journal.pgen.1000579.s001 (0.02 MB PDF)
Table S1 Microsatellites.
Found at: doi:10.1371/journal.pgen.1000579.s002 (0.02 MB
XLS)
Figure 4. Multispecies alignment of the SERPINH1 protein sequence. The SERPINH1 protein sequence is highly conserved among all
vertebrates. The p.L326P mutation in OI Dachshunds is indicated by an arrow. It affects a leucine residue, which is perfectly conserved from human to
zebrafish across all investigated species. The sequences for the alignment were taken from the following accessions: XP_542305 (dog), NP_001226
(human), NP_001039528 (cattle), XP_001494735 (horse), NP_033955 (mouse), NP_058869 (rat), NP_990622 (chicken), NP_001080259 (Xenopus laevis),
NP_571279 (zebrafish).
doi:10.1371/journal.pgen.1000579.g004
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Table S2 Results of homozygosity mapping.
Found at: doi:10.1371/journal.pgen.1000579.s003 (0.04 MB
XLS)
Table S3 List of dog breeds tested for SERPINH1 exon 5 SNPs.
Found at: doi:10.1371/journal.pgen.1000579.s004 (0.02 MB
XLS)
Table S4 Primer sequences for the amplification of canine
SERPINH1 coding exons.
Found at: doi:10.1371/journal.pgen.1000579.s005 (0.02 MB
XLS)
Table S5 Primer sequences for the amplification of canine
SERPINH1 cDNA.
Found at: doi:10.1371/journal.pgen.1000579.s006 (0.03 MB
XLS)
Video S1 Affected Dachshund puppy showing wobbly gait due
to ligament hyperlaxity and unstable joints, especially the carpal
joints.
Found at: doi:10.1371/journal.pgen.1000579.s007 (6.96 MB AVI)
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